Asr Vermogensbeheer N.V. Exact Sciences Corp Transaction History
Asr Vermogensbeheer N.V.
- $8.24 Trillion
- Q3 2025
A detailed history of Asr Vermogensbeheer N.V. transactions in Exact Sciences Corp stock. As of the latest transaction made, Asr Vermogensbeheer N.V. holds 16,948 shares of EXAS stock, worth $1.12 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
16,948
Previous 17,143
1.14%
Holding current value
$1.12 Million
Previous $911 Million
1.79%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding EXAS
# of Institutions
655Shares Held
159MCall Options Held
1.43MPut Options Held
2.35M-
Capital World Investors Los Angeles, CA18.2MShares$1.2 Billion0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.8MShares$1.18 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$799 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12MShares$794 Million0.12% of portfolio
-
State Street Corp Boston, MA5.38MShares$356 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $11.7B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...